<DOC>
	<DOCNO>NCT01337141</DOCNO>
	<brief_summary>A great visit frequency diabetes mellitus 1 ( DM1 ) patient medical team increase possibility improve metabolic control . The support telematic visit support patient health system . Patients Method : 160 patient ( 5 participate centre ) type 1 diabetes mellitus ( DM1 ) candidate improve metabolic control select accord inclusion exclusion criterion . The telecare system use comprised patient Unit doctor Unit . The system allow patient send glucose value , insulin dos , carbohydrate contribution event via internet . Both patient professional use information via telecare system platform . Work hypothesis The application interactive telematic system patient-health team improve cost effectiveness care program optimisation metabolic control direct towards diabetes mellitus ( DM1 ) patient . Objectives : General Objective Evaluate impact telecare system efficiency economic clinical management human material resource direct program metabolic control optimisation diabetes mellitus 1 ( DM1 ) patient well level metabolic control quality life patient . Specific objectives 1 . To identify analyse influence telecare system patient cost time , money normal work school activity patient stop carry physical visit follow programme . 2 . To identify analyse influence telecare system medical team cost time , money care organisation direct towards monitor phase metabolic control care programme . 3 . To identify analyse influence telecare system level metabolic control : Glycosylated haemoglobin presence acute hypoglycemic hyperglycaemic complication diabetes mellitus 1 ( DM1 ) patient follow metabolic optimisation programme . 4 . To identify analyse influence telecare system quality life patient measure satisfaction scale , impact , social/work concern concern relate diabetes . 5 . To identify analyse influence telecare system adherence different treatment component .</brief_summary>
	<brief_title>A Telematic Program Optimization Metabolic Control Diabetes Mellitus Type 1 ( DM1 ) Patients</brief_title>
	<detailed_description>*Title : Multicentric random , prospective , open comparative intervention study evaluate efficiency implementation Spanish Health System telematic system apply metabolic control optimization type 1 diabetes mellitus ( DM1 ) patient . - Protocol : 1 ) Pre-intervention . After patient inform accepts protocol make 2 visit plan individual treatment . 2 ) Random Assignment 2 Groups : A ) Intervention ( telecare system ) . B ) Control . The intervention group patient train telecare system machine . Both group make number 6 visit 6 month : Intervention Group ( 5 telematics 1 hospital ) , Control group ( 6 hospital ) . Results assess 3 6 month reassess 12 month . - Patients The objective present study demonstrate telematic control diabetes mellitus inferior face face visit control system , show add value important reduction cost . Cost information three study use calculation sample 2,3,20 diabetes mellitus 1 ( DM1 ) patient , follow telematic form ( 210 ± 184€ ) form face face visit ( 376 ± 278€ ) . Relating , 72 patient per group need obtain statistical power 99 % alpha level 0.05 ( two-sided ) . 80 patient per group need randomise take account 10 % loss percentage . Participating Centres - Hospital Clínico . Barcelona - Hospital Clínico . Valencia - Hospital Carlos Haya . Málaga - Hospital Clínico . Madrid - Hospital de Cruces . Barakaldo Each arm include 80 patient , 160 total .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<criteria>Diabetes Mellitus 1 ( DM1 ) patient 5 year evolution value glycosylated haemoglobin ( HbA1c ) &gt; 8 % age 18 50 year . Undergoing treatment multiple dos insulin . Having 34 blood sugar test per day . Suitable knowledge diabetes ( test Diabetes knowledge questionnaire ( DKQ2 ) &gt; 25 ) . Patients computer access home internet . Pregnant diabetes mellitus 1 ( DM1 ) patient . History severe hypoglycemia . Manipulation result . Psychiatric disorder . Incapable carry intensive therapy monitoring . Physical and/or visual incapacity . Participating another study . Patients infertility treatment ( ISCI ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Telemedicine</keyword>
	<keyword>Type 1 diabetes</keyword>
	<keyword>Metabolic control optimisation</keyword>
	<keyword>Health care cost</keyword>
	<keyword>Intervention study</keyword>
	<keyword>Access internet</keyword>
</DOC>